University Services Assists Physicians Managing Patients with Chronic Pain by Reviewing Over 1 Million Pain Management Drug Screens

Share Article

University Services, a Toxicology Services company, has reviewed over 1 million drug screens for physicians treating patients with chronic pain by determining inconsistencies between what a patient was prescribed versus what was found in their system.

"The growing trend for prescription use, misuse, and abuse coincides with the growth of our Pain Management Medical Review business," commented Dr. Benjamin Gerson

The Institute of Medicine Report from the Committee on Advancing Pain Research, Care, and Education, states chronic pain affects 116 million Americans each year. According to the American Academy of Pain Medicine, the cost to society is at least $560-$635 billion annually, an amount equal to $2,000 for everyone living in the U.S. This includes the total incremental cost of health care due to pain ranging between $261 to $300 billion and $297-$336 billion due to lost productivity (based on days of work missed, hours of work lost, and lower wages). According to the 2009 National Survey on Drug Use and Health, prescription drugs used to treat chronic pain are the second-most abused category of drugs in the United States, following marijuana, and the 2009 Findings on Drug Related Emergency Department Visits from SAMSHA estimated the number of emergency department visits linked to non-medical use of prescription pain relievers nearly doubled between 2004 and 2009.

Clinicians use urine drug screens as an effective way of documenting treatment compliance, detecting drug diversion, and identifying substance abuse. University Services developed an electronic system with drug testing laboratories that allow medical staff to easily identify the inconsistencies between what a patient should have in their system and what a urinalysis provides. This information gives prescribing physicians the information they need to learn how their patients are adhering to treatment.

"The growing trend for prescription use, misuse, and abuse coincides with the growth of our Pain Management Medical Review business,” commented Dr. Benjamin Gerson, Medical Director of University Services, “our Medical Staff review thousands of screens each week and have found 56% of screens are inconsistent, proving just how much physicians should investigate this option for their patients.”

University Services, a physician owned and operated Pennsylvania Corporation was organized in 1967 as a supplier of multi-specialty medical services. The company’s main activities related to toxicology services include design & implementation of substance abuse testing programs, Medical Review Officer Services, and pain management drug screen reviews.

If you’d like more information about this topic, or to schedule an interview with Dr. Benjamin Gerson, please call Crystal Bayawa at 215-637-6800 or email cbayawa(at)uservices(dot)com.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Crystal Bayawa
University Services
(215) 637-6800 x102
Email >
Visit website